Urinary retention. Bladder-neck obstruction
Conditions
Interventions
Intervention 1: Tamsulosin capsule 4 mg mg daily dose started 7 days before surgery and will continue from zero to 2 days after surgery. The type of oral capsule will be provided to the patient. Urina
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years Male and female Ability to complete the informed consent form to participate in the study Accepting the schedule of participation in the study and the time of surgery and the fact that she must remain in the hospital for at least 1 night after surgery
Exclusion criteria
Exclusion criteria: Sensitivity or contraindication to the use of tamsulosin Severe hypersensitivity to sulfa drugs Use of the current alpha-blocker (alphazosin, doxazosin, prazosin, terazosin, verapamil, tamsulosin) or oral alpha agonists, or the initiation of any of these drugs during the start of the intervention phase of the study, which will cause the patient to drop out. Take warfarin now Use of a Foley catheter, suprapubic catheter or urostomy Dialysis patients or patients with less than 200 cc of urine per day Predicting the patient's inability to use the drug orally after surgery Lack of conscious consent to participate in the study Patients who use a Foley catheter chronically Patients are expected to be transferred to the ICU after surgery. Patients with a history of severe heart failure or major cardiovascular events in the past 6 months Use beta-blockers, acetylcholinesterase inhibitors, or drugs that interfere with tamsulosin and betanacol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary retention rate. Timepoint: 7 days before surgery and 0 to 2 days after surgery. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKaveh Haddadi
Mazandaran University of Medical Sciences
Outcome results
None listed